Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/27862
DC FieldValueLanguage
dc.contributor.authorPanovska Stavridis, Irinaen_US
dc.contributor.authorEftimov, Aleksandaren_US
dc.contributor.authorIvanovski, Martinen_US
dc.contributor.authorStojanovic, Aleksandaren_US
dc.contributor.authorGeorgievski, Borcheen_US
dc.contributor.authorChevrevska, Lidijaen_US
dc.contributor.authorDimovski, Aleksandaren_US
dc.date.accessioned2023-09-07T10:12:12Z-
dc.date.available2023-09-07T10:12:12Z-
dc.date.issued2016-08-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/27862-
dc.description.abstractAcquired calreticulin (CALR) gene mutations are one of the molecular hallmarks of essential thrombocythemia (ET). It has been suggested that patients with ET with CALR mutations are associated with a distinct clinical phenotype.en_US
dc.language.isoenen_US
dc.publisherElsevier BVen_US
dc.relation.ispartofClinical lymphoma, myeloma & leukemiaen_US
dc.titleDiversities of Calreticulin Gene Mutations in Macedonian Patients With Essential Thrombocythemiaen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.clml.2016.04.019-
dc.identifier.urlhttps://api.elsevier.com/content/article/PII:S2152265016300623?httpAccept=text/xml-
dc.identifier.urlhttps://api.elsevier.com/content/article/PII:S2152265016300623?httpAccept=text/plain-
dc.identifier.volume16-
dc.identifier.issue8-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Pharmacy-
Appears in Collections:Faculty of Medicine: Journal Articles
Прикажи едноставен запис

Page view(s)

75
checked on 4.5.2025

Google ScholarTM

Проверете

Altmetric


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.